Tan Sri Dato'
Dr Abu Bakar bin Suleiman
(30 March 2011 - 31 December 2017)

Dear Shareholders,

Five successful years on, as a dually listed public entity on Bursa Malaysia and SGX, IHH Healthcare Berhad marked another major milestone. The year 2016 saw India, previously a key market, join the ranks of our three home markets of Malaysia, Singapore and Turkey. We expanded our geographical footprint to better serve patients, further entrenching ourselves in Asia as well as Central and Eastern Europe, Middle East and North Africa (CEEMENA). The impetus for our growth came on the back of pent-up demand for quality healthcare amid changing demographics as well as increasing affluence and private insurance coverage.



The year saw the Group achieving several key milestones and reinforcing our leadership position. We entered a new market in Bulgaria, and consolidated our position in India after the transformational acquisitions of the Continental and Global Hospitals in 2015. We also fortified our presence in key growth markets including China. In China, we are developing our tertiary facilities ― a 350-bed hospital in the city of Chengdu and a 450-bed multi-specialty hospital within Shanghai New Hongqiao International Medical Centre. We took measures to strengthen our growth prospects in China through a strategic partnership with Taikang Insurance Group. The partnership is subject to both parties fulfilling the necessary conditions for completion, including regulatory approvals.

Click here to view our Chairman's Statement

Source Date: 31 March 2017